Oral anticoagulants in older adults with atrial fibrillation.
Publication
, Journal Article
Bernacki, GM; Becker, RC
Published in: Journal of thrombosis and thrombolysis
November 2013
Atrial fibrillation (AF) is the most common arrhythmia in adults and contributes directly to adverse clinical events, ranging from ischemic stroke to heart failure and cardiovascular death. Because the incidence of AF and its attendant complications increase with age, there is a strong and growing need to develop safe, effective and widely available therapies. The following review summarizes the use of oral anticoagulants in older adults with AF, focusing on practical topics such as drug metabolism, drug-drug interactions, co-morbidities and cost considerations in a complex payer environment.
Duke Scholars
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
November 2013
Volume
36
Issue
4
Start / End Page
403 / 415
Related Subject Headings
- Middle Aged
- Male
- Humans
- Female
- Drug Interactions
- Costs and Cost Analysis
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
- Aging
Citation
APA
Chicago
ICMJE
MLA
NLM
Bernacki, G. M., & Becker, R. C. (2013). Oral anticoagulants in older adults with atrial fibrillation. Journal of Thrombosis and Thrombolysis, 36(4), 403–415. https://doi.org/10.1007/s11239-013-0869-0
Bernacki, Gwen M., and Richard C. Becker. “Oral anticoagulants in older adults with atrial fibrillation.” Journal of Thrombosis and Thrombolysis 36, no. 4 (November 2013): 403–15. https://doi.org/10.1007/s11239-013-0869-0.
Bernacki GM, Becker RC. Oral anticoagulants in older adults with atrial fibrillation. Journal of thrombosis and thrombolysis. 2013 Nov;36(4):403–15.
Bernacki, Gwen M., and Richard C. Becker. “Oral anticoagulants in older adults with atrial fibrillation.” Journal of Thrombosis and Thrombolysis, vol. 36, no. 4, Nov. 2013, pp. 403–15. Epmc, doi:10.1007/s11239-013-0869-0.
Bernacki GM, Becker RC. Oral anticoagulants in older adults with atrial fibrillation. Journal of thrombosis and thrombolysis. 2013 Nov;36(4):403–415.
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
November 2013
Volume
36
Issue
4
Start / End Page
403 / 415
Related Subject Headings
- Middle Aged
- Male
- Humans
- Female
- Drug Interactions
- Costs and Cost Analysis
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
- Aging